Hemophilia B

6 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Hematologic Diseases

Treatments and conditions

Hemophilia B
Treatment and conditionWhere it standsTrials
CSL222 (AAV5-hFIXco-Padua) for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
CSL222 (Adeno-associated viral vector serotype 5 [AAV5]-hFIXco-Padua) for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fidanacogene Elaparvovec for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Fitusiran for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Marstacimab for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
SR604 for hemophilia bPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.